Pharmacokinetics of Vildagliptin in Mild, Moderate and Severe Renal Impaired Patients

Clinical trial NCT00818571 · COMPLETED

Trial details

NCT number: NCT00818571
Sponsor: Novartis Pharmaceuticals
Status: COMPLETED
Phase: Phase 1, Phase 2
Study type: INTERVENTIONAL

Renal Impairment Diabetes

Start date: 2008-12-01
Primary completion: 2009-05-01
Enrollment: 96

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.